Frank Grund
University of Oslo
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Frank Grund.
American Journal of Physiology-heart and Circulatory Physiology | 1999
Frank Grund; Hilchen T. Sommerschild; Torstein Lyberg; Knut Arvid Kirkebøen; Arnfinn Ilebekk
Coronary microembolization has been reported to increase coronary blood flow (CBF) through adenosine release. Because adenosine may increase ischemic tolerance against infarction, we tested the hypothesis that myocardial microembolization, a common finding in patients with ischemic heart disease, induces cardioprotection. Additionally, because the use of microspheres is a common tool to measure tissue perfusion, the effects of small amounts of microspheres on CBF were examined. Using anesthetized pigs, we measured CBF with a transit time flow probe on the left anterior descending coronary artery (LAD). In six pigs the relationship between the amount of injected microspheres (0-40 × 106, 15 μm in diameter, left atrial injections) and the effect on CBF was examined. Coronary hyperemia occurred, which was linearly related to the amount of microspheres injected: maximal increase in CBF (%) = 2.8 ± 1.5 (SE) + (5.8 ± 0.7 × 10-7 × number of injected microspheres). Because injection of 40 × 106 microspheres induced a long-lasting hyperemic response, which could be blocked by 8- p-sulfophenyl theophylline, ischemic tolerance was examined in five other pigs after two injections, each of 40 × 106microspheres, at a 30-min interval. Six control pigs had no injections. Ischemic tolerance was evaluated by measuring infarct size (tetrazolium stain) as the percentage of area at risk (fluorescent particles) after 45 min of LAD occlusion followed by 2 h of reperfusion. Pretreatment by microspheres increased infarct size from 60 ± 3% of area at risk in control animals to 84 ± 6% ( P< 0.05). The injection of microspheres induced a significant hyperemic flow response without causing necrosis by itself. We conclude that microembolization, evoking coronary hyperemia, does not improve but reduces myocardial ischemic tolerance against infarction in pigs.Coronary microembolization has been reported to increase coronary blood flow (CBF) through adenosine release. Because adenosine may increase ischemic tolerance against infarction, we tested the hypothesis that myocardial microembolization, a common finding in patients with ischemic heart disease, induces cardioprotection. Additionally, because the use of microspheres is a common tool to measure tissue perfusion, the effects of small amounts of microspheres on CBF were examined. Using anesthetized pigs, we measured CBF with a transit time flow probe on the left anterior descending coronary artery (LAD). In six pigs the relationship between the amount of injected microspheres (0-40 x 10(6), 15 micrometer in diameter, left atrial injections) and the effect on CBF was examined. Coronary hyperemia occurred, which was linearly related to the amount of microspheres injected: maximal increase in CBF (%) = 2.8 +/- 1.5 (SE) + (5.8 +/- 0.7 x 10(-7) x number of injected microspheres). Because injection of 40 x 10(6) microspheres induced a long-lasting hyperemic response, which could be blocked by 8-p-sulfophenyl theophylline, ischemic tolerance was examined in five other pigs after two injections, each of 40 x 10(6) microspheres, at a 30-min interval. Six control pigs had no injections. Ischemic tolerance was evaluated by measuring infarct size (tetrazolium stain) as the percentage of area at risk (fluorescent particles) after 45 min of LAD occlusion followed by 2 h of reperfusion. Pretreatment by microspheres increased infarct size from 60 +/- 3% of area at risk in control animals to 84 +/- 6% (P < 0.05). The injection of microspheres induced a significant hyperemic flow response without causing necrosis by itself. We conclude that microembolization, evoking coronary hyperemia, does not improve but reduces myocardial ischemic tolerance against infarction in pigs.
Basic Research in Cardiology | 1997
Frank Grund; Hilchen T. Sommerschild; Knut Arvid Kirkebøen; Arnfinn Ilebekk
Conflicting data exist on how ischemic preconditioning affects the incidence of arrhythmias during ischemia. The present study was, therefore, performed to clarify if ischemic preconditioning alters the incidence of arrhythmias during the early phase of ischemia in pigs.Twenty-four pigs (23–36.5 kg) in pentobarbital anesthesia were preconditioned by a 10 min LAD-occlusion and 30 min reperfusion prior to a second 10 min occlusion. The first occlusion served as the preconditioning ischemic period, and the second occlusion as the test ischemic period. To verify that the preconditioning protocol induced protection, infarct size was assessed in an additional nine pigs.The arrhythmic index (arrhythmic beats/min) increased from 12±3 during the first occlusion to 38±8 during the second occlusion (P<0.05). Four pigs (17%) fibrillated during the first ischemic period, while 10 pigs (42%) fibrillated during the second ischemic period (P<0.05). All pigs that fibrillated during the first occlusion also fibrillated during the second occlusion. Mean heart rate was 108±4 beats/min before the first occlusion and increased to 113±4 beats/min before the second occlusion (P<0.001). There was a positive correlation between heart rate before the second occlusion and occurrence of fibrillation during this occlusion (rs=0.42; P<0.05). The preconditioning protocol reduced infarct size, after a subsequent 45 min ischemic period followed by two hours of reperfusion, from 58±3% of area at risk to 40±5% (P<0.05).In conclusion, our data show that ischemic preconditioning increases both the arrhythmic index and the incidence of ventricular fibrillation during the early phase of a subsequent ischemic period.
Laboratory Animals | 2004
Frank Grund; O. Tjomsland; I. Sjaastad; Arnfinn Ilebekk; Knut Arvid Kirkebøen
The present study was performed to compare haemodynamic variables at baseline and the incidence of ventricular fibrillation during the early phase of ischaemia in swine during pentobarbital or medetomidine-ketamine-fentanyl anaesthesia. Twenty-two swine (mean ± SD: 29± 3 kg) were anaesthetized with sodium pentobarbital (induction with 36 mg/kg intraperitoneally, and maintenance with 5-20 mg/kg/h intravenously [i.v.]) and 6 swine (27± 3 kg) were anaesthetized with ketamine and fentanyl (premedicated with medetomidine 0.1 mg/kg and ketamine 10 mg/kg intramuscularly, induction with ketamine 20 mg/kg and fentanyl 0.025 mg/kg i.v., and maintenance with ketamine 20 mg/kg/h and fentanyl 0.025 mg/kg/h i.v.). After a stabilization period of 30 min, the left anterior descending coronary artery (LAD) was occluded for 10 min. Haemodynamic data and occurrence of ventricular fibrillation were recorded. The ischaemic area was measured by fluorescing microspheres. Swine anaesthetized with medetomidine-ketamine-fentanyl had significantly lower heart rate, myocardial contractility, peak left ventricular pressure, arterial blood pressure, aortic blood flow, myocardial blood flow and cardiac index at baseline, than swine anaesthetized with pentobarbital. Whereas none of the swine anaesthetized with pentobarbital fibrillated during the LAD occlusion, ventricular fibrillation occurred in 83% of the animals anaesthetized with medetomidine-ketamine-fentanyl (P< 0.001). No significant difference was found in size of ischaemic area between the two groups. Thus, we show a depression in haemodynamic variables at baseline and a higher incidence of ventricular fibrillation during the early phase of ischaemia in swine anaesthetized with medetomidine-ketamine-fentanyl compared to swine anaesthetized with pentobarbital.
Circulation | 1997
Hilchen T. Sommerschild; Frank Grund; Jon Offstad; Per Jynge; Arnfinn Ilebekk; Knut Arvid Kirkebøen
BACKGROUND Adenosine has several potentially cardioprotective effects. We hypothesized that the effects of endogenous adenosine vary with degree of ischemia and that elevating endogenous levels is protective. METHODS AND RESULTS Isolated blood-perfused piglet hearts underwent 120 minutes of low-flow ischemia (10% flow) or 90 minutes of zero-flow ischemia, all with 60 minutes of reperfusion. Hearts were treated with either saline, the adenosine receptor blocker 8-sulfophenyltheophylline (8SPT, 300 micromol x L(-1)), or the nucleoside transport inhibitor draflazine (1 micromol x L(-1)). In separate groups, biopsies were obtained before and at the end of ischemia. Compared with saline, 8SPT did not significantly alter functional recovery in either protocol. Draflazine significantly improved percent recovery of left ventricular systolic pressure both in the low-flow protocol (92+/-3% versus 75+/-2% [saline] and 73+/-3% [8SPT], P<.001 for both) and in the zero-flow protocol (76+/-3% versus 59+/-4% [saline] and 46+/-9% [8SPT], P<.05 for both). In the zero-flow protocol, draflazine also significantly reduced ischemic contracture and release of creatine kinase. Tissue adenosine at the end of ischemia was elevated by draflazine compared with saline-treated hearts: after low-flow ischemia to 0.10+/-0.05 versus 0.00+/-0.00 micromol x g(-1) dry wt (P<.05) and after zero-flow ischemia to 1.73+/-0.82 versus 0.15+/-0.03 micromol x g(-1) dry wt (P<.05). CONCLUSIONS In neonatal porcine hearts, endogenous adenosine produced during ischemia does not influence ischemic injury or functional recovery. Elevating endogenous adenosine by draflazine elicits cardioprotection in both low-flow and zero-flow conditions.
Journal of Molecular and Cellular Cardiology | 1997
Frank Grund; Hilchen T. Sommerschild; Knut Arvid Kirkebøen; Arnfinn Ilebekk
Acta Physiologica Scandinavica | 1997
Frank Grund; Hilchen T. Sommerschild; A. Winecoff; M. R. Ujhelyi; Theis Tønnessen; Knut Arvid Kirkebøen; D. L. Rutlen; Arnfinn Ilebekk
Basic Research in Cardiology | 1998
Hilchen T. Sommerschild; Jon Offstad; Frank Grund; Arnfinn Ilebekk; Knut Arvid Kirkebøen
Journal of Applied Physiology | 1998
Frank Grund; Hilchen T. Sommerschild; Knut Arvid Kirkebøen; Arnfinn Ilebekk
Journal of Molecular and Cellular Cardiology | 1999
Frank Grund; Knut Gjesdal; Knut Arvid Kirkebøen; Arnfinn Ilebekk
Acta Physiologica Scandinavica | 1995
Frank Grund; Hilchen T. Sommerschild; Knut Arvid Kirkebøen; Arnfinn Ilebekk